Medivir medivir.se

Xerclear has been developed by Medivir in Stockholm, Sweden. Medivir is active in the research and development of pharmaceuticals against a range of diseases, including hepatitis C, osteoporosis, HIV and shingles. The company has a range of partnerships with established pharmaceutical companies and smaller biotech enterprises on clinical and preclinical projects. Xerclear is the first pharmaceutical Medivir has developed in-house, which it is launching.

Xerclear has been developed by Medivir in Stockholm, Sweden. Medivir is active in the research and development of pharmaceuticals against a range of diseases, including hepatitis C, osteoporosis, HIV and shingles. The company has a range of partnersh...Show all

See All Exits Recent Exits

Medivir - Investments & Acquisitions

Show Real Data Medivir Investments
See all Recent Investments
Date Company Round Amount Co-investors
2013-06-25Cross PharmaAcquired Unit
2007-03-13Epiphany BiosciencesSeries A$36MCDIB BioScience Venture Management, and Wexford Capital
See all 2 investments